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INTRODUCTION:  This  case  highlights  the complexities  in  the initial  diagnosis  and  investigations  of
widespread  lytic lesions  initially  perceived  to be  a  widespread  metastatic  process  and  the  consideration
of  alternative  diagnosis.
PRESENTATION  OF  CASE:  A  57 year-old  man  with  a background  of  psoriatic  arthritis  presented  to  the
rheumatology  department  with  lumbar  back  pain  and  sensory  disturbance  over  L4/5.  Magnetic  reso-
nance  imaging  (MRI) and bone  scan  identiﬁed  lesions  consistent  with  bony  metastases  at L5.  The  patient
previously  had  a  raised  prostate  speciﬁc  antigen  (PSA)  of  10.8  g/L (normal  <  4)  but  prostate  biopsy was
benign.
Multiple  metastatic  deposits  in the liver  and kidneys  (conﬁrmed  necrotic  tissue  on  biopsy)  were  iden-
tiﬁed  through  further  investigations.  The  initial diagnosis  of malignancy  was  challenged  after  a  positron
emission  tomography  (PET)  scan  showed  lesions  highly  suggestive  of  polyarteritis  nodosa  (PAN)  and
subsequent  magnetic  resonance  angiogram  (MRA)  revealed  stenosis  and  aneurysm  in the  renal  artery  in
keeping  with  PAN.  Therefore  what  was  initially  thought  to be a  widespread  metastatic  disease  process
was  in  fact  the manifestation  of a systemic  vasculitic  disease.
DISCUSSION:  PAN  is a vasculitis  that  predominantly  involves  small  to medium-sized  vessels.  The  disease
can  affect  any site  in the body,  but holds  a  predisposition  for  organs  such  as kidneys,  heart  and  the
gastrointestinal  tract.  Differential  diagnosis  of  PAN  should  be considered  in patients  with  widespread
lytic  lesions.
CONCLUSION:  Due  to  the pathological  nature  of  PAN  and  its  variable  clinical  manifestations  that  add  to
the challenges  of  its diagnosis,  one  must  hold  a high  clinical  suspicion,  even  in urological  conditions.
© 2015  Published  by Elsevier  Ltd.  on  behalf  of  IJS  Publishing  Group  Ltd.  This  is  an  open  access  article
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. Introduction
This case highlights the complexities in the initial diagnosis and
nvestigations of widespread lytic lesions initially perceived to be a
idespread metastatic process and the consideration of alternative
iagnosis. Furthermore identiﬁcation is made of the rare overlap
f differential diagnosis of disease processes between urology and
heumatology and the robust multi-disciplinary and cross specialty
upport required for this resolution.
. Presentation of caseA 57 year-old man  with a background of psoriatic arthritis
treated with disease modifying agents) presented to the rheuma-
ology department with lumbar back pain and sensory disturbance
ver L4/5. The patient’s only relevant medical history revealed
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urological surveillance of PSA, which rose from 4.0 g/L (2008)
to 10.8 g/L (2012). Initial transrectal and further transperineal
template-guided prostate biopsies were benign. On further history
taking it was  noted that the patient had sustained a weight loss of
two stones with night sweats, and had symptoms of polyneuropa-
thy and calf claudication.
Examination revealed localised lumbar-sacral tenderness, with
no focal neurological deﬁcit. The duration and nature of the symp-
toms led to an MRI  which identiﬁed destructive lesions at L5
vertebra and a subsequent bone scan revealed increased uptake in
the L5 vertebra and left hip highly suggestive of a metastatic pro-
cess from a primary tumor of an unknown origin (Fig. 1). In view of a
benign prostatic biopsy an attempt was  made to further investigate
the primary source.
CT scan of the chest/abdomen/pelvis revealed multiple
metastatic deposits in the liver (Fig. 2), both kidneys (Fig. 3), Iliac
bones and left sacroiliac joint. At this stage concern was  expressed
if the primary malignancy originated from the hepatic or renal
system. After extensive multidisciplinary team discussion (MDT),
histological examination was obtained from ultrasound guided
biopsies of the liver and renal lesion, which identiﬁed necrotic
is an open access article under the CC BY-NC-ND license (http://creativecommons.
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Fig. 1. Sagittal MRI  view demonstrating collapse of L5 vertebral body suggestive of
metastatic disease.
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Fig. 3. Axial CT image of renal lesions initially suggestive of metastatic disease.
Fig. 4. MR  angiogram image demonstrating luminal irregularity and alternatingig. 2. Axial CT image demonstrating liver lesions initially suggestive of metastatic
isease.
issue only. A PET scan was performed to reﬁne the differential
iagnostic list. The report suggested ﬂuorodeoxyglucose (FDG) neg-
tive lesions in the liver, kidney and bone, characteristic of infarcts
ather than metastatic deposits, all of which were strongly sugges-
ive of PAN. An MRA  was  preformed which identiﬁed a stenosis and
neurysm of the left renal artery with areas of post-inﬂammatory
hanges—supporting the diagnosis of PAN (Fig. 4).
Rheumatoid factor and Cytoplasmic antineutrophil cytoplas-
ic  antibody (cANCA) were positive but antinuclear antibodies
ANA) and antibodies against myeloperoxidase (MPO), serine pro-
einase (PR3) or hepatitis B virus were negative. Complete blood
ount (CBC), urea, creatinine, electrolytes (Na & K), complements
3 and C4 as well as uric acid were normal. Erythrocyte sedimen-
ation rate measured 36 and C-reactive protein (CRP) was  61 mg/Lfocal dilatation of the left distal renal artery and narrowing in keeping with stenosis
and mild aneurysm suggestive of vasculitis.
(normal < 4). In addition, Beta 2 microglobulin was  slightly elevated
at 2.68 mg/L (normal limit 2.40) and urine protein creatinine ratio
(PCR) was  9.
Initial differential diagnosis encompassed metastatic lesions
from multiple primary sources including prostate cancer, renal cell
carcinoma and hepatocellular carcinoma. Later on PAN became evi-
dent as a serious contender for the primary diagnosis.
Given systemic history of malaise, weight loss, night sweats,
large joint arthritis, MRA  ﬁndings and FDG PET showing features
of renal, hepatic and bony infarcts, a diagnosis of PAN was  made
and the patient was  commenced on immunosuppressive regimen
aimed at inducing remission. Patient was  started on high dose oral
steroids (Prednisolone 60 mg)  and methotrexate 25 mg/week.
At presentation the patient had a Birmingham Vasculitis Activ-
ity Score (BVAS) of ten and on one month follow up the patient
reported signiﬁcant improvement in clinical symptoms particularly
back pain and lower limb paraesthesia and attained a BVAS of zero
with normal inﬂammatory markers. He had no further weight loss
and reported weight gain reaching premorbid levels. A repeat MRI
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f the abdomen showed a reduction in the size of the hepatic and
enal lesions further excluding a malignant process. He is under
egular follow up with the rheumatology department where he has
uccessfully undergone steroid taper regimen and is currently on
 modest dose of steroids and oral methotrexate. He is undertak-
ng active physiotherapy including hydrotherapy to improve the
umbosacral discomfort and is contemplating return to work.
. Discussion
PAN is a vasculitis that predominantly involves small to
edium-sized vessels. The disease can affect any site in the body,
ut holds a predisposition for organs such as kidneys (93%), heart
72%), the gastrointestinal tract (57%), with several reports high-
ighting involvement of the testes and prostate [1,2]. Signs and
ymptoms result from the ischemic changes to the affected organ,
herefore its presentation can be very variable and adds to the chal-
enges of its diagnosis. The exact etiology is unknown and vast
ajority of the cases are idiopathic in origin while a small number
re secondary to infections like Hepatitis B and systemic diseases
ike systemic lupus erythematosus (SLE), rheumatoid arthritis (RA),
jogrens etc. It is difﬁcult to attribute a clear link immunologically
etween Psoriasis/Psoriatic arthritis and PAN, but there are some
eports, which have shown isolated association between PAN and
soriatic arthritis and spondyloarthritis [3,4].
As demonstrated in this case, diagnosis can be challenging and
as historically dependent upon histology (according to the Chapel
ill Consensus criteria [5]) and an angiogram demonstrating a renal
rtery aneurysm. There are no diagnostic laboratory tests for PAN
nd the current ACR (American college of Rheumatology) classiﬁ-
ation criteria provides a sensitivity and speciﬁcity of 82 and 87%
espectively for the diagnosis of PAN provided 3 of the 10 criteria
re satisﬁed. PAN commonly affects middle aged or older adults
ith incidence rising with age reaching a peak at 6th decade [6].
here is 1.5:1 male predominance. The 5-year survival following
reatment with immunosuppression ranges between 75 and 80%
7].
Vast amount of literature is available on PAN. Ambrosio et al.
ighlight a case report that demonstrates an atypical manifestation
f PAN presenting as a renal mass in a patient with angioim-
unoblastic T-cell lymphoma (AITL) (sub-type of peripheral T cell
ymphoma) [8]. However, the complexities of this case were differ-
nt from our case as it postulated a relationship of an autoimmune
rocess by the lymphoma leading to vessel wall injury and thus
AN. In our case we do not demonstrate causality but rather the
ide scope of differentials postulated by PAN’s pathological mani-
estation.
Bing et al. reported a case of PAN presenting clinically in a 46
ear old ﬁt male with loin pain and frank haematuria following an
pisode of strenuous exercise [9]. Initial concerns of renal trauma
ere subsided by investigations revealing an intra-renal aneurysm,
onﬁrming PAN as a diagnosis and its resolution following a course
f immunosuppressive therapy.
. ConclusionThe purpose of our case report was to demonstrate the consid-
ration of PAN as a serious contender in the differential diagnosis
f widespread lytic lesions, when no other primary source can be
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identiﬁed. Because of the pathological nature of PAN and its variable
clinical manifestations adding to the challenges of its diagnosis, one
must hold a high clinical suspicion of its diagnosis even in urological
conditions.
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